Demo-Umgebung · Gesundheitsdaten sind synthetisch · Studien und laufende Trials sind echt (Europe PMC · ClinicalTrials.gov)
VITA LONGA Longevity Intelligence
Anmelden
Research Radar

Was gerade untersucht wird

48 laufende klinische Studien, live aus ClinicalTrials.gov — 5 davon mit einem Standort in Deutschland.

Laufend Deutschland Schlaf

A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

The present phase 1b/2 randomised, double-blind, placebo-controlled, two-part study is designed to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of two dose levels of golexanolone comp…

NCT07304843 ·n=84 ·PHASE1/PHASE2 Details ↗
Rekrutierend Deutschland Schlaf

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe infla…

NCT07196722 ·n=1092 ·PHASE2/PHASE3 Details ↗
Laufend Deutschland Schlaf

A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

The purpose of this study is to evaluate treatment persistence with guselkumab and interleukin-17 inhibitor (IL-17i) initiated at enrollment into this study (PsABIOnd).…

NCT05049798 ·n=1314 Details ↗
Laufend Deutschland ApoB, LDL & Herz

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study dr…

NCT06292013 ·n=17300 ·PHASE3 Details ↗
Rekrutierend Deutschland ApoB, LDL & Herz

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.…

NCT07157774 ·n=10450 ·PHASE3 Details ↗

Quelle: ClinicalTrials.gov API v2, gefiltert auf rekrutierende und laufende Studien.